【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: PIPELINE ANALYSIS
PART 07: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Biologics – Market size and forecast 2018-2023
• Non-biologics – Market size and forecast 2018-2023
• Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
• PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Strategic focus on alliances, partnerships, and M&A
• Emergence of combination therapies and novel targets
• Rising demand for genetic tests and protein biomarkers
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bristol-Myers Squibb Co.
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson Services Inc.
• Novartis AG
• Takeda Pharmaceutical Co. Ltd.
PART 15: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 16: EXPLORE TECHNAVIO
Exhibit 01: Recent mega-mergers in pharmaceuticals
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ billions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Some of the first-in-class orphan drugs approved by the US FDA during 2017-2018
Exhibit 11: Five forces analysis 2018
Exhibit 12: Five forces analysis 2023
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition – Five forces 2018
Exhibit 19: Some of the late-stage orphan drugs
Exhibit 20: Product – Market share 2018-2023 (%)
Exhibit 21: Comparison by product
Exhibit 22: Biologics – Market size and forecast 2018-2023 ($ billions)
Exhibit 23: Number of new or expanded indications approved for novel orphan biologics to the number of rare and non-rare diseases from the US FDA January 2013-June 2019
Exhibit 24: Promising regenerative orphan drugs pricing plans
Exhibit 25: Biologics – Year-over-year growth 2019-2023 (%)
Exhibit 26: Non-biologics – Market size and forecast 2018-2023 ($ billions)
Exhibit 27: Non-biologics – Year-over-year growth 2019-2023 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Market share by geography 2018-2023 (%)
Exhibit 31: Geographic comparison
Exhibit 32: North America – Market size and forecast 2018-2023 ($ billions)
Exhibit 33: Number of orphan drug approvals in US 2014-2018
Exhibit 34: US FDA orphan drug marketing approvals in major therapeutic areas 2008-2017
Exhibit 35: List of expensive orphan drugs launched in US
Exhibit 36: Leading vendors and their product sales in US 2018.
Exhibit 37: Status of BTD, PR, and ODD for novel drugs 2013-2017
Exhibit 38: RMAT designation requests by product type 2018
Exhibit 39: North America – Year-over-year growth 2019-2023 (%)
Exhibit 40: Europe – Market size and forecast 2018-2023 ($ billions)
Exhibit 41: Orphan drug approvals in Europe during 2010-2018
Exhibit 42: Applications for ODD in EU 2005-2018
Exhibit 43: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 44: Asia – Market size and forecast 2018-2023 ($ billions)
Exhibit 45: Orphan drugs eligible for reimbursable under China’s state health insurance schemes
Exhibit 46: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 47: ROW – Market size and forecast 2018-2023 ($ billions)
Exhibit 48: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 49: Key leading countries
Exhibit 50: Market opportunity
Exhibit 51: List of promising drugs approved in US, Japan, and EU 2017-2019
Exhibit 52: Number of orphan drugs approved in US, EU, and Japan 2017 and 2018
Exhibit 53: Percentage of orphan and non-orphan drugs approved by the US FDA 2018
Exhibit 54: Incidence rate of rare diseases per year in US
Exhibit 55: Prevalence of rare diseases 2018 (millions)
Exhibit 56: Orphan drugs regulatory framework and incentives in key leading regions or countries
Exhibit 57: Impact of drivers and challenges
Exhibit 58: Several major M&A in the market
Exhibit 59: Expansion of combination therapies research areas of ICI approved drugs
Exhibit 60: Ongoing immunotherapy combinations studies with co-inhibitory molecules
Exhibit 61: Ongoing immunotherapy combinations studies with co-stimulatory molecules
Exhibit 62: Vendor landscape
Exhibit 63: Landscape disruption
Exhibit 64: Vendors covered
Exhibit 65: Vendor classification
Exhibit 66: Market positioning of vendors
Exhibit 67: Bristol-Myers Squibb Co. – Vendor overview
Exhibit 68: Bristol-Myers Squibb Co. – Business segments
Exhibit 69: Bristol-Myers Squibb Co. – Organizational developments
Exhibit 70: Bristol-Myers Squibb Co. – Geographic focus
Exhibit 71: Bristol-Myers Squibb Co. – Key offerings
Exhibit 72: Bristol-Myers Squibb Co. – Key customers
Exhibit 73: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 74: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 75: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 76: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 77: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 78: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 79: F. Hoffmann-La Roche Ltd. – Key customers
Exhibit 80: Johnson & Johnson Services Inc. – Vendor overview
Exhibit 81: Johnson & Johnson Services Inc. – Business segments
Exhibit 82: Johnson & Johnson Services Inc. – Organizational developments
Exhibit 83: Johnson & Johnson Services Inc. – Geographic focus
Exhibit 84: Johnson & Johnson Services Inc. – Segment focus
Exhibit 85: Johnson & Johnson Services Inc. – Key offerings
Exhibit 86: Johnson & Johnson Services Inc. – Key customers
Exhibit 87: Novartis AG – Vendor overview
Exhibit 88: Novartis AG – Business segments
Exhibit 89: Novartis AG – Organizational developments
Exhibit 90: Novartis AG – Geographic focus
Exhibit 91: Novartis AG – Segment focus
Exhibit 92: Novartis AG – Key offerings
Exhibit 93: Novartis AG – Key customers
Exhibit 94: Takeda Pharmaceutical Co. Ltd. – Vendor overview
Exhibit 95: Takeda Pharmaceutical Co. Ltd. – Business segments
Exhibit 96: Takeda Pharmaceutical Co. Ltd. – Organizational developments
Exhibit 97: Takeda Pharmaceutical Co. Ltd. – Geographic focus
Exhibit 98: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibit 99: Takeda Pharmaceutical Co. Ltd. – Key customers
Exhibit 100: Validation techniques employed for market sizing
Exhibit 101: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル：オーファンドラッグ（希少疾患治療薬）の世界市場2019-2023■ 英文：Orphan Drugs Market by Product and Geography - Global Forecast and Analysis 2019-2023
■ 発行日：2019年8月26日
■ 調査会社：Technavio
■ 商品コード：IRTNTR31893
■ 調査対象地域：グローバル、アジア太平洋、ヨーロッパ、北米、その他
- 医薬品販売業務受託機関（CSO）の世界市場Outsourced selling of medicines – how to find trends, opportunities and potential revenues What’s the future of outsourcing pharma sales activities? For prescription drugs, get new forecasts for contracted promotional activities. Stay ahead, then, for data. There you explore business results, progress, trends, strategies and predicted revenues. Visiongain’s updated report shows what’s possible for …
- 2014 Assessments of Blood Typing, Grouping and Screening Market–Strategic Profiles of Leading SuppliersThis new 225-page report from Venture Planning Group presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing innovative blood banking technologies and products.The report also presents strategic assessments of cur …
- グーグルVS競合企業：コマース市場-ウォレット・システム（Google vs. Competitors: Commerce Market ? Wallet Systems）A battle is raging in the mobile commerce arena in the area of mobile payments. Google is battling against others literally for (electronic) wallet share. The stakes are high because whomever wins the battle for wallet share will have a huge advantage when it comes to actual mobile commerce. Payment solutions can be categorized on the basis of the payment settlement methods, which are instant-paid …
- 梅毒検査の世界市場2015-2019About syphilis testing Syphilis is a type of sexually transmitted infections disease caused by the bacteria Treponema pallidum subspecies pallidum. The infection spreads mainly through sexual contact. Congenital syphilis, however, affects infants by transmission of the infection from the infected mother to the fetus. The rate of syphilis infection is high among men and particularly in those men wh …
- 受動型赤外線モーションセンサーの世界市場2016-2020About Passive Infrared Motion Sensor A PIR motion sensor detects infrared (IR) radiation to detect the presence of an object in its close proximity. Most objects with temperature exceeding absolute zero generally radiate heat energy at the wavelengths of infrared lights. A PIR-based sensor device does not generate any heat while detecting IR radiation. The sensors are capable of identifying the di …
- 世界のCMV検査市場The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- 世界の装置産業におけるフィールドバス・ソリューション市場（2014-2018）About Global Fieldbus Solution market for the Process Industry A Fieldbus is a two-way communication digital network operating in physical, data and application layers of the OSI model. It is a control network used across process automation, enabling the field devices to be connected with the controller. Process industries across the globe are increasing using fieldbus incorporated measurement ins …
- フィットネスアプリの世界市場ABSTRACTAbout Fitness App Fitness apps are mobile applications that allow users to use their smartphones for tracking and monitoring fitness and sports activities. These apps track the fitness levels of users, measure their heart rates, and the calories lost while exercising and doing day-to-day activities. Technavio’s analysts forecast the global fitness app market to grow at a CAGR of 29.45% dur …
- クラウドコンピューティングの世界市場予測（～2023年）Increasing need to deliver enhanced customer experience to drive the cloud computing marketThe global cloud computing market size is expected to grow from USD 272.0 billion in 2018 to USD 623.3 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 18.0% during the forecast period. Increased automation and agility, need for delivering enhanced customer experience, and increased cost savings a …
- 世界のプリンテッド&フレキシブルセンサー市場動向（2012-2016）TechNavio's analysts forecast the Global Printed and Flexible Sensor market to grow at a CAGR of 0.84 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low cost of manufacturing printed and flexible sensors. The market has also been witnessing the miniaturization of sensor devices. However, lack of technology standards could pose a challenge to the …
- 世界におけるサービス品質管理(SQM)及び通信事業者の顧客経験管理(CEM)市場予測と分析The Service Quality Management (SQM) and Telco Customer Experience Management (CEM) market is segmented on the basis of types of product, channels, end users, providers, and regions. Under each region, the market has been classified based on types of channels and analytics. Traditionally, companies focused mainly on their products and not on customers. However, with the rise in competition across …
- ベビー浴用石鹸の世界市場2016-2020About Baby Bath Soap Market Based on the product type, the market can be segmented into medicated and non-medicated baby soap segments. MEA and APAC are among the most attractive retail targets globally and exhibit high growth potential for the market. The regions have the largest population of children in the world, which is the main reason for their high growth potential, not only for baby bath …
- 世界のADC（抗体－薬物複合体）市場展望（～2018）The ADC technology is not new. It dates back to the 90s. However, several issues such as specificity of the payload (drug), and poor conjugation of drug and antibody proved a setback. But, the past few years have witnessed ADCs make a glorious comeback. This can be attributed to the significant advancements that have been made in the field of linker technology as well as payload efficacy and speci …
- たばこ製造・販売企業分析：Gudang GaramSynopsis This report provides a unique and comprehensive analysis of the company Global, Regional and National Tobacco Players: Gudang Garam, including the corporate profile, organisation structure, financial data, and competitive positioning. The analysis also details the organisation's history, merger and acquisition activity, licensing agreements, brand portfolio, as well as an assessment of co …
- 世界の吸収式冷凍機市場：Global Absorption Chillers Market 2014-2018TechNavio forecasts The Global Absorption Chillers Market 2014-2018 with a CAGR of 3.94 percent for the period 2014-2018. Several driving factors and trends will contribute to this growth-all of which will be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors t …
